Efficacy of Oral Ibandronate in Osteoporosis

Phase 2UnknownNCT03186131

Shinshu University100 enrolled

Overview

There has been no comparative data between oral ibandronate and oral ibandronate plus active vitamin D

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

100

Conditions

Osteoporosis

Interventions

IbandronateDRUG

To examine the efficacy of oral Ibandronate in osteoporosis

Oral Ibandronate and Vitamin DDRUG

To examine the efficacy of oral Ibandronate and Vitamin D in osteoporosis

Eligibility

Sex: ALLMin age: 20 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Osteoporotic patients who want to take oral ibandronate Exclusion Criteria: * Patients who are allergic to oral ibandronate or vitamin D Patients who have not taken oral ibandronate for the last 2 years

Locations (1)

Yukio Nakamura

Matsumoto, Nagano, Japan

RECRUITING

Outcomes

Primary Outcomes

Bone mineral density

Time frame: Change from Baseline Values at 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.